{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:54:35Z","timestamp":1780048475360,"version":"3.53.1"},"reference-count":56,"publisher":"Ubiquity Press, Ltd.","issue":"4","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["gh"],"DOI":"10.1016\/j.gheart.2016.06.001","type":"journal-article","created":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T01:00:28Z","timestamp":1477011628000},"page":"305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Secondary CV Prevention in South America in a Community Setting: The PURE\n                        Study"],"prefix":"10.5334","volume":"12","author":[{"given":"Alvaro","family":"Avezum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo B.F.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Lanas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio","family":"Lopez-Jaramillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Jaime","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Seron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Camacho-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Orlandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Bernabe-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f4nio","family":"Cordeiro Mattos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shofiqul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumathy","family":"Rangarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koon","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3285","published-online":{"date-parts":[[2017,12,1]]},"reference":[{"key":"10.1016\/j.gheart.2016.06.001_bib1","unstructured":"Pan American Health Organization. Regional Health Observatory: Indicadores B\u00e1sicos de Salud: Mortalidad: Causas principales de defunci\u00f3n 2010. Available at: http:\/\/ais.paho.org\/phip\/viz\/mort_causasprincipales_lt_oms.asp. Accessed in January 1, 2016."},{"key":"10.1016\/j.gheart.2016.06.001_bib2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.gheart.2014.01.006","article-title":"Stroke in Latin America: burden of disease and opportunities for prevention","volume":"10","author":"Avezum","year":"2015","journal-title":"Glob Heart"},{"key":"10.1016\/j.gheart.2016.06.001_bib3","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1161\/hc4601.099487","article-title":"Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization","volume":"104","author":"Yusuf","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.gheart.2016.06.001_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"385","author":"GBD 2013 Mortality and Causes of Death Collaborators","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.gheart.2016.06.001_bib5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","author":"Global Burden of Disease Study 2013 Collaborators","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.gheart.2016.06.001_bib6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":"Beta blockade during and after myocardial infarction: an overview of the randomized trials","volume":"27","author":"Yusuf","year":"1985","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.gheart.2016.06.001_bib7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(06)69201-5","article-title":"Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials","volume":"368","author":"Dagenais","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.gheart.2016.06.001_bib8","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.gheart.2016.06.001_bib9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy\u2014I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","author":"Antiplatelet Trialists' Collaboration","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.gheart.2016.06.001_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0140-6736(02)09358-3","article-title":"Two decades of progress in preventing vascular disease","volume":"360","author":"Yusuf","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.gheart.2016.06.001_bib11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.gheart.2015.04.003","article-title":"Reducing premature cardiovascular morbidity and mortality in people with atherosclerotic vascular disease: the World Heart Federation Roadmap for secondary prevention of cardiovascular disease","volume":"10","author":"Perel","year":"2015","journal-title":"Glob Heart"},{"key":"10.1016\/j.gheart.2016.06.001_bib12","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.2105\/AJPH.2012.301024","article-title":"The Brazilian Family Health Program and secondary stroke and myocardial infarction prevention: a 6-year cohort study","volume":"102","author":"Cabral","year":"2012","journal-title":"Am J Public Health"},{"key":"10.1016\/j.gheart.2016.06.001_bib13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cpcardiol.2009.10.002","article-title":"Growing epidemic of coronary heart disease in low- and middle-income countries","volume":"35","author":"Gaziano","year":"2010","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.gheart.2016.06.001_bib14","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1311890","article-title":"Cardiovascular risk and events in 17 low-, middle-, and high-income countries","volume":"371","author":"Yusuf","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gheart.2016.06.001_bib15","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(11)61215-4","article-title":"Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE study): a prospective epidemiological survey","volume":"378","author":"Yusuf","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.gheart.2016.06.001_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2009.04.019","article-title":"The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries","volume":"158","author":"Teo","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.gheart.2016.06.001_bib17","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.gheart.2016.06.001_bib18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0140-6736(10)60834-3","article-title":"Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study","volume":"376","author":"O'Donnell","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.gheart.2016.06.001_bib19","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1161\/01.STR.0000199147.30016.74","volume":"37","author":"Sacco","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.gheart.2016.06.001_bib20","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(09)60330-5","article-title":"Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries","volume":"373","author":"Kotseva","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.gheart.2016.06.001_bib21","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjcard.2008.06.037","article-title":"Discordance between physicians' estimation of patient cardiovascular risk and use of evidence-based medical therapy","volume":"102","author":"Tsang","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.gheart.2016.06.001_bib22","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1177\/1741826711418166","article-title":"Compliance with cardiovascular drug prevention measures in a general population: the Multidisciplinary Intervention in Primary Care (IMAP) study","volume":"19","author":"Lopez-Carmona","year":"2012","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.gheart.2016.06.001_bib23","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.amjmed.2011.12.013","article-title":"Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients","volume":"125","author":"Naderi","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.gheart.2016.06.001_bib24","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s11606-012-2308-x","article-title":"Key barriers to medication adherence in survivors of strokes and transient ischemic attacks","volume":"28","author":"Kronish","year":"2013","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.gheart.2016.06.001_bib25","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gheart.2016.06.001_bib26","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/clc.22217","article-title":"Predictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH registry","volume":"36","author":"Rodriguez","year":"2013","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.gheart.2016.06.001_bib27","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.amjmed.2013.01.033","article-title":"Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis","volume":"126","author":"Kumbhani","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.gheart.2016.06.001_bib28","first-page":"820","article-title":"WHO study on Prevention of REcurrences of Myocardial Infarction and StrokE (WHO-PREMISE)","volume":"83","author":"Mendis","year":"2005","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.gheart.2016.06.001_bib29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/1755-5922.12060","article-title":"Cardiovascular medication use following percutaneous coronary intervention: the Australian experience","volume":"32","author":"Cole","year":"2014","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.gheart.2016.06.001_bib30","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4067\/S0034-98872013000800003","volume":"141","author":"Nazzal","year":"2013","journal-title":"Rev Med Chil"},{"key":"10.1016\/j.gheart.2016.06.001_bib31","first-page":"39","article-title":"Effect of age, gender, ethnicity, socioeconomic status and region on dispensing of CVD secondary prevention medication in New Zealand: the Atlas of Health Care Variation CVD cohort (VIEW-1)","volume":"127","author":"Kerr","year":"2014","journal-title":"N\u00a0Z Med J"},{"key":"10.1016\/j.gheart.2016.06.001_bib32","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.282.15.1458","article-title":"Why don't physicians follow clinical practice guidelines? A framework for improvement","volume":"282","author":"Cabana","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.gheart.2016.06.001_bib33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2261-10-25","article-title":"Availability, price and affordability of cardiovascular medicines: a comparison across 36 countries using WHO\/HAI data","volume":"10","author":"van Mourik","year":"2010","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.gheart.2016.06.001_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000333","article-title":"Quantifying the impoverishing effects of purchasing medicines: a cross-country comparison of the affordability of medicines in the developing world","volume":"7","author":"Niens","year":"2010","journal-title":"PLoS Med"},{"key":"10.1016\/j.gheart.2016.06.001_bib35","doi-asserted-by":"crossref","first-page":"58","DOI":"10.18553\/jmcp.2014.20.1.58","article-title":"Medication adherence in a sample of elderly suffering from hypertension: evaluating the influence of illness perceptions, treatment beliefs, and illness burden","volume":"20","author":"Rajpura","year":"2014","journal-title":"J\u00a0Manag Care Pharm"},{"key":"10.1016\/j.gheart.2016.06.001_bib36","first-page":"644","article-title":"Comparison of uptake and predictors of adherence in primary and secondary prevention of cardiovascular disease in a community-based cardiovascular prevention programme (MyAction Westminster)","volume":"36","author":"Murray","year":"2014","journal-title":"J\u00a0Public Health (Oxf)"},{"key":"10.1016\/j.gheart.2016.06.001_bib37","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s11096-013-9908-3","article-title":"Use of medications for secondary prevention in stroke patients at hospital discharge in Australia","volume":"36","author":"Eissa","year":"2014","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.gheart.2016.06.001_bib38","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.amjmed.2014.03.011","article-title":"Secondary prevention after ischemic stroke or transient ischemic attack","volume":"127","author":"Bangalore","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.gheart.2016.06.001_bib39","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00228-013-1609-2","article-title":"Long-term use of antiplatelet drugs by patients with transient ischaemic attack","volume":"70","author":"Ostergaard","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.gheart.2016.06.001_bib40","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1177\/2047487314546825","article-title":"Control of main risk factors after ischaemic stroke across Europe: data from the stroke-specific module of the EUROASPIRE III survey","volume":"22","author":"Heuschmann","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.gheart.2016.06.001_bib41","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/jnnp-2012-303267","article-title":"Secondary prevention in patients with vascular disease: a population based study on the underuse of recommended medications","volume":"84","author":"Bejot","year":"2013","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.gheart.2016.06.001_bib42","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1161\/STROKEAHA.109.566950","article-title":"Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke","volume":"41","author":"Glader","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.gheart.2016.06.001_bib43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-2377-14-53","article-title":"Clinical factors associated with statins prescription in acute ischemic stroke patients: findings from the Lombardia Stroke Registry","volume":"14","author":"Canavero","year":"2014","journal-title":"BMC Neurol"},{"key":"10.1016\/j.gheart.2016.06.001_bib44","first-page":"1703","article-title":"Underuse of statins in patients with atherosclerotic ischemic stroke in China","volume":"125","author":"Li","year":"2012","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.gheart.2016.06.001_bib45","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.04.026","article-title":"A\u00a0prescription at discharge improves long-term adherence for secondary stroke prevention","volume":"23","author":"Tsai","year":"2014","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.gheart.2016.06.001_bib46","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ahj.2013.02.011","article-title":"Gender and racial disparities in adherence to statin therapy: a meta-analysis","volume":"165","author":"Lewey","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.gheart.2016.06.001_bib47","doi-asserted-by":"crossref","first-page":"E449","DOI":"10.1503\/cmaj.131807","article-title":"Lifestyle factors as predictors of nonadherence to statin therapy among patients with and without cardiovascular comorbidities","volume":"186","author":"Halava","year":"2014","journal-title":"CMAJ"},{"key":"10.1016\/j.gheart.2016.06.001_bib48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/1708538113484022","article-title":"Evaluation on the compliance with secondary prevention and influence factors of ischemic stroke in Hainan Province, China","volume":"22","author":"Su","year":"2014","journal-title":"Vascular"},{"key":"10.1016\/j.gheart.2016.06.001_bib49","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cjca.2013.07.680","article-title":"Characteristics and evidence-based management of stable coronary artery disease patients in Canada compared with the rest of the world: insights from the CLARIFY registry","volume":"30","author":"Gandhi","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.gheart.2016.06.001_bib50","doi-asserted-by":"crossref","first-page":"g4014","DOI":"10.1136\/bmj.g4014","article-title":"Impact of primary health care on mortality from heart and cerebrovascular diseases in Brazil: a nationwide analysis of longitudinal data","volume":"349","author":"Rasella","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.gheart.2016.06.001_bib51","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/JAC.0b013e31819940f7","article-title":"A\u00a0multimodal strategy based on pay-per-performance to improve quality of care of family practitioners in Argentina","volume":"32","author":"Rubinstein","year":"2009","journal-title":"J\u00a0Ambul Care Manage"},{"key":"10.1016\/j.gheart.2016.06.001_bib52","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/inthealth\/iht039","article-title":"Impact of a novel community-based lifestyle intervention program on type 2 diabetes and cardiovascular risk in a resource-poor setting in the Dominican Republic","volume":"6","author":"West-Pollak","year":"2014","journal-title":"Int Health"},{"key":"10.1016\/j.gheart.2016.06.001_bib53","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/heapro\/dam025","article-title":"Emergence Model of social and human capital and its application to the Healthy Municipalities project in Northeast Brazil","volume":"22","author":"Yuasa","year":"2007","journal-title":"Health Promot Int"},{"key":"10.1016\/j.gheart.2016.06.001_bib54","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.gheart.2014.10.006","article-title":"World Heart Federation Emerging Leaders Program: an innovative capacity building program to facilitate the 25 x 25 goal","volume":"10","author":"Huffman","year":"2015","journal-title":"Glob Heart"},{"key":"10.1016\/j.gheart.2016.06.001_bib55","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0140-6736(15)60265-3","article-title":"The World Heart Federation's vision for worldwide cardiovascular disease prevention","volume":"386","author":"Yusuf","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.gheart.2016.06.001_bib56","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ahj.2013.04.019","article-title":"Prospective Urban Rural Epidemiology (PURE) study: baseline characteristics of the household sample and comparative analyses with national data in 17 countries","volume":"166","author":"Corsi","year":"2013","journal-title":"Am Heart J"}],"container-title":["Global Heart"],"original-title":[],"link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211816016307001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211816016307001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/doi.org\/10.1016\/j.gheart.2016.06.001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T12:49:18Z","timestamp":1657543758000},"score":1,"resource":{"primary":{"URL":"https:\/\/globalheartjournal.com\/article\/10.1016\/j.gheart.2016.06.001\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,1]]},"references-count":56,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,12,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.gheart.2016.06.001","relation":{},"ISSN":["2211-8179","2211-8160"],"issn-type":[{"value":"2211-8179","type":"electronic"},{"value":"2211-8160","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secondary CV Prevention in South America in a Community Setting","name":"articletitle","label":"Article Title"},{"value":"Global Heart","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gheart.2016.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 World Heart Federation (Geneva). Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}